Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume

M Desai, A Kundu, M Hageman, H Lou, D Boisvert - MAbs, 2023 - Taylor & Francis
Biologic drugs are used to treat a variety of cancers and chronic diseases. While most of
these treatments are administered intravenously by trained healthcare professionals, a …

Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions

A Schneider, R Jost, C Jordi, J Lange - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction The growing interest in subcutaneous delivery of larger single-dose volumes
using handheld autoinjectors raises questions about the feasible upper limits for injection …

Quantifying Patient Capabilities and Setting the Stage for Future Development: Insights from a Sensor-Augmented Simulated Use Study with Pen Injectors

J Lange, AE Schneider, C Jordi - Medical Devices: Evidence and …, 2024 - Taylor & Francis
Background While formative and summative usability testing is essential to confirm safe and
effective product use, it may not be sufficient to comprehensively understand user …

[HTML][HTML] 1. Surgical/Critical Care Flexible Nutrition and Drug Delivery Supports Patient-Centered Care March 26, 2024

K Nadeau - hpnonline.com
Flexible Nutrition and Drug Delivery Supports Patient-Centered Care | Healthcare Purchasing
News Healthcare Purchasing News Magazine Continuing Education Webinars Whitepapers …